ZHOU Yuanyuan, ZHOU Jue, XU Biao, SUN Mingxia. Analysis of nosocomial infection status and prognosis in intensive care unit of a traditional Chinese medicine hospital[J]. Journal of Clinical Medicine in Practice, 2023, 27(10): 117-123. DOI: 10.7619/jcmp.20223883
Citation: ZHOU Yuanyuan, ZHOU Jue, XU Biao, SUN Mingxia. Analysis of nosocomial infection status and prognosis in intensive care unit of a traditional Chinese medicine hospital[J]. Journal of Clinical Medicine in Practice, 2023, 27(10): 117-123. DOI: 10.7619/jcmp.20223883

Analysis of nosocomial infection status and prognosis in intensive care unit of a traditional Chinese medicine hospital

More Information
  • Received Date: December 28, 2022
  • Revised Date: March 13, 2023
  • Available Online: June 06, 2023
  • Objective 

    To investigate the prevalence trend and drug resistance status of multidrug-resistant bacteria in nosocomial infection in intensive care unit (ICU) of a traditional Chinese medicine hospital in Jiangsu Province, and analyze the risk factors of prognosis of patients with nosocomial infection.

    Methods 

    The clinical data of patients with nosocomial infection in ICU of Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine from January 2019 to December 2021 were retrospectively analyzed. The pathogenic spectrum and drug resistance of multidrug-resistant bacteria were analyzed. The patients with nosocomial infection were divided into survival group and death group according to the prognosis. Logistic regression was used to explore the risk factors of death in patients with nosocomial infection, and the receiver operating characteristic (ROC) curve was drawn to evaluate the predictive value of each risk factor on the death in patients with nosocomial infection in ICU.

    Results 

    A total of 242 patients were included in this study, among whom 173 (71.49%) were infected by multidrug-resistant bacteria. The majority of bacteria was Gram-negative bacteria, and showed a significant upward trend from 2019 to 2021, among which the proportion of Klebsiella pneumoniae was the highest and increased year by year, and the proportion of carbapenem-resistant Klebsiella pneumoniae was also increased year by year. Of the 242 patients, 157 (64.88%) survived and 85 (35.12%) died. The univariate analysis showed that compared with the survival group, the Acute Physiology And Chronic Health Evaluation Ⅱ (APACHE Ⅱ) score, sequential organ failure assessment (SOFA) score, cystatin C and serum creatinine levels in the death group were significantly increased, the prealbumin level was significantly decreased, and the proportions of patients with shock, central venous catheterization and invasive mechanical ventilation for more than 7 days were significantly increased (P < 0.05). Logistic regression analysis of risk factors showed that increased SOFA score (OR=1.146; 95%CI, 1.026 to 1.279; P=0.016), invasive mechanical ventilation for more than 7 days (OR=2.010; 95%CI, 1.049 to 3.854; P=0.035), and reduced prealbumin (OR=0.992; 95%CI=0.988 to 0.997; P=0.001) were independent risk factors for death of patients with nosocomial infection in ICU. The ROC curve showed that prealbumin and SOFA scores for predicting the death of patients with nosocomial infection in ICU were 0.646 and 0.678, respectively, and their best cut-off values were 111.5 mg/L and 6.5, respectively. The AUC of the combined test was 0.719.

    Conclusion 

    The situation of Gram-negative multidrug-resistant bacteria infection in ICU patients with nosocomial infection is serious. In the past three years, the proportion and drug resistance rate of Klebsiella pneumoniae increased year by year, and the treatment is difficult. Prolonged time of invasive mechanical ventilation, decreased prealbumin level and high SOFA score are independent risk factors for poor prognosis of patients with nosocomial infection in ICU.

  • [1]
    ARAÇ E, KAYA Ş, PARLAK E, et al. Evaluation of infections in intensive care units: a multicentre point-prevalence study[J]. Mikrobiyol Bul, 2019, 53(4): 364-373. doi: 10.5578/mb.68665
    [2]
    DE WAELE J J, BOELENS J, LEROUX-ROELS I. Multidrug-resistant bacteria in ICU: fact or myth[J]. Curr Opin Anaesthesiol, 2020, 33(2): 156-161. doi: 10.1097/ACO.0000000000000830
    [3]
    中华人民共和国卫生部. 医院感染诊断标准(试行)[J]. 中华医学杂志, 2001, 81(5): 314-320. doi: 10.3760/j:issn:0376-2491.2001.05.027
    [4]
    MAGIORAKOS A P, SRINIVASAN A, CAREY R B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance[J]. Clin Microbiol Infect, 2012, 18(3): 268-281. doi: 10.1111/j.1469-0691.2011.03570.x
    [5]
    康焰, 朱仕超. 借助院内感染控制做好重症医学科内的重症感染管理[J]. 中华内科杂志, 2017, 56(5): 335-336. doi: 10.3760/cma.j.issn.0578-1426.2017.05.005
    [6]
    MODI A R, KOVACS C S. Hospital-acquired and ventilator-associated pneumonia: Diagnosis, management, and prevention[J]. Cleve Clin J Med, 2020, 87(10): 633-639. doi: 10.3949/ccjm.87a.19117
    [7]
    程洁, 陈新, 祝振忠, 等. 采用机械通气的老年肺部感染呼吸衰竭患者多重耐药及相关因素分析[J]. 实用临床医药杂志, 2021, 25(14): 20-23. doi: 10.7619/jcmp.20211680
    [8]
    MORKAR D N, DWIVEDI M, PATIL P. Comparative study of sofa, Apache ii, saps ii, as a predictor of mortality in patients of Sepsis admitted in medical ICU[J]. J Assoc Physicians India, 2022, 70(4): 11-12.
    [9]
    王金荣, 高攀, 郭淑芬, 等. ICU患者医院感染的死亡危险因素分析: 2009年至2015年864例病例回顾[J]. 中华危重病急救医学, 2016, 28(8): 704-708. doi: 10.3760/cma.j.issn.2095-4352.2016.08.007
    [10]
    HALTMEIER T, INABA K, DURSO J, et al. Transthyretin at admission and over time as a marker for clinical outcomes in critically ill trauma patients: a prospective single-center study[J]. World J Surg, 2020, 44(1): 115-123. doi: 10.1007/s00268-019-05140-6
    [11]
    ISSEVER K, GENC A C, CEKIC D, et al. Prealbumin: a new biomarker for predicting prognosis in patients with severe COVID-19[J]. J Coll Physicians Surg Pak, 2021, 31(7): S99-S103. http://doc.paperpass.com/foreign/rgPrep20218297894.html
    [12]
    WANG C Y, YE S, WANG X C, et al. Clinical efficacy and safety of mechanical ventilation combined with fiberoptic bronchoalveolar lavage in patients with severe pulmonary infection[J]. Med Sci Monit, 2019, 25: 5401-5407. doi: 10.12659/MSM.915507
    [13]
    PAPAZIAN L, KLOMPAS M, LUYT C E. Ventilator-associated pneumonia in adults: a narrative review[J]. Intensive Care Med, 2020, 46(5): 888-906. doi: 10.1007/s00134-020-05980-0
    [14]
    黄正米, 杨晓帆, 荣清源, 等. 重症监护病房发生医院获得性肺炎的病原学特点及风险模型构建[J]. 实用临床医药杂志, 2021, 25(23): 27-30, 36. doi: 10.7619/jcmp.20212528
    [15]
    ADEOSUN P O, FATUSI O A, ADEDEJI T A. Assessment of severity of illness and monitoring response to treatment of odontogenic space infection using serum prealbumin[J]. J Maxillofac Oral Surg, 2019, 18(1): 106-111. doi: 10.1007/s12663-018-1105-4
  • Cited by

    Periodical cited type(9)

    1. 李国良,王海久,周虎,潘彪. 含雷替曲塞化疗方案的介入手术在中晚期肝细胞癌治疗中的研究进展. 实用药物与临床. 2025(01): 66-73 .
    2. 熊日晖,袁国辉,赵新华. 柴胡化积汤联合经肝动脉化疗栓塞术在原发性肝癌姑息治疗中的应用效果观察. 中国当代医药. 2024(03): 104-107+111 .
    3. 李森,邓俊魁,胡欣. 表柔比星联合奥沙利铂经导管动脉栓塞化疗治疗中晚期原发性肝癌患者的临床疗效. 癌症进展. 2024(09): 1033-1036 .
    4. 王明玉. 载药微球肝动脉化疗栓塞术与碘油肝动脉化疗栓塞术治疗不可切除肝癌的效果比较. 实用临床医学. 2024(03): 14-17 .
    5. 王东彩,仝永方,韩珍珍. 原发性肝癌患者经肝动脉化疗栓塞术治疗后癌因性疲乏发生的影响因素及管理对策分析. 黑龙江医学. 2024(17): 2058-2061 .
    6. 王花,黑悦,孙淼,孙延闯,韩娟,孙娟华. 贝伐珠单抗联合雷替曲塞治疗不可切除肝细胞癌的疗效及对不良反应和生存率影响. 实用医学杂志. 2024(21): 3061-3066 .
    7. 胡钧文,杨清梅,华杨,李永敏. 雷替曲塞与氟尿嘧啶对不可切除肝癌患者的疗效观察. 河北医药. 2023(05): 715-718 .
    8. 王洪伟,安萃萃,刘超,海青. 雷替曲塞联合顺铂在原发性肝癌肝动脉化疗栓塞术中的应用价值分析. 中外医疗. 2023(28): 60-63 .
    9. 潘嫚,杨业勤. 奥沙利铂联合表柔比星治疗原发性肝癌的效果. 中国卫生标准管理. 2022(23): 119-122 .

    Other cited types(1)

Catalog

    Article views (161) PDF downloads (8) Cited by(10)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return